INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR
|
|
- Erick Bertram Hensley
- 8 years ago
- Views:
Transcription
1 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation policies, the patient's treatment history and diagnosis documentation should be reviewed by a Nurse Reviewer or Case Manager who has been specially trained in transplantation and oncology. If there is uncertainty regarding coverage, the case should be referred to a physician reviewer. For individual policy description and coverage information, please refer to the Medical Policies listed in the RELATED POLICIES section. RELATED POLICIES: Colony Stimulating Factors G-CSF (Filgrastim, Neupogen) OR GM-CSF (Sargramostim, Prokine) - RX Information on Organ and Tissue Transplantation - SUR Peripheral/Bone Marrow Stem Cell Transplantation (PSCT/BMT) for Non- Malignancies - SUR Peripheral/Bone Marrow Stem Cell Transplantation (PSCT/BMT) for Malignancies - SUR Cord Blood as a Source of Stem Cells (CBSC) - SUR Donor Leukocyte Infusion - SUR Tandem/Triple High-Dose Chemoradiotherapy with Autologous Stem Cell Support for Malignancies - SUR DESCRIPTION: Human blood contains a remarkable variety of cells, each precisely tailored to its own vital function. Erythrocytes, or red blood cells, transport life-sustaining oxygen throughout the body. Tiny platelets stop bleeding by promoting clotting. White blood cells (eg. lymphocytes, monocytes, and neutrophils) form the immune system that guards against attack by foreign tissue, viruses, and various other microorganisms. All of these cells develop from master cells or blood cell progenitors (the Hematopoietic [blood-forming or blood-parent] Stem Cell [HSC]) which reside primarily in bone marrow. Injury to the stem cells, from chemotherapy, radiation, or disease, can cripple the immune and blood production systems. Stem cells can be harvested from three sources: the bone marrow, peripheral blood, or umbilical cord blood. When stem cells are harvested from and infused back into the same individual, the procedure is referred to as Autologous (Au). When stem cells from a healthy antigen compatible (histocompatible) donor are harvested and then infused into a different recipient, the
2 procedure is referred to as Allogeneic (Allo). Syngeneic stem cels refer to genetically identical bone marrow or peripheral stem cells harvested from an identical twin. Syngeneic transplants are obviously limited by the rarity of identical twins. These procedures are, also known as: Hematopoietic Stem Cell Support (HSCS or SCS), Peripheral Stem Cell Transplantation (PSCT), Stem Cell Rescue (previously referred to as Transplant), or Bone Marrow Transplantation (BMT). Stem cells are the main ingredient in BMTs. The stem cells in the transplanted marrow can reestablish the patient's blood-producing and immune systems, which have been devastated by leukemia, cancer, chemotherapy, radiation therapy, or unknown causes. The transplant procedure itself is simple. If the patient is not self-donating his/her bone marrow, it is obtained from a donor individual and is known as Allogeneic Bone Marrow Transplantation (AlloBMT). The bone marrow is aspirated from the iliac crests of the pelvis of: a related or unrelated donor who is human lymphocyte antigen (HLA) compatible (allogeneic), or a related donor who is HLA-identical (syngeneic). If the patient is self-donating his/her bone marrow, known as Autologous Bone Marrow Transplantation (AuBMT), the bone marrow is removed from the iliac crests of the pelvis when a complete remission has been induced. The patient is then given High Dose Chemotherapy (HDC) with the hope of destroying any residual tumor. HDC is a regimen of cytoxic agents that are several times higher than the standard therapeutic dose. This is done to treat malignancy but it may also ablate the patient's bone marrow. The rationale for HDC is that many cytotoxic agents act according to a steep dose-response curve. Therefore, small, increasing doses of the cytotoxic agent will result in large increases of the tumor cell kill. In addition, the increasing doses increase the incidence and severity of adverse effects, such as opportunistic infections, hemorrhage, and organ failure. Since the life-threatening toxicity is so high, patients are usually hospitalized for the HDC regimen and may require further hospitalization to treat the drug toxicity effects. In some regimens to eradicate the tumor cells, whole body or localized radiotherapy may be given with the HDC agents, known as chemoradiotherapy. A subsequent rescue with the patient's own bone marrow or the donated allogeneic or syngeneic bone marrow follows the HDC. BMTs present numerous medical hurdles. The patient must receive a steady supply of fresh red cells, platelets, and antibiotics for several weeks until the transplanted stem cells begin producing large quantities of mature blood elements. In an AlloBMT, the patient's immune system must be sufficiently suppressed so that it will not reject the transplanted stem cells. At the same time, the immune system cells produced by the donor stem cells may recognize their new host as foreign, a reaction known as Graft Versus Host Disease (GVHD), in which case they may cause organ damage and/or death. AuBMT eliminates the need to find a compatible marrow donor and bypasses the risk of GVHD.
3 Patients treated with HDC regimens that ablate their own bone marrow function are increasingly being reinfused with autologous Peripheral Blood Stem Cells rather than with bone marrow cells. After several cycles of conventional doses of chemotherapy and stimulation with Colony Stimulating Factors (CSFs), the number of hematopoietic stem cells in the peripheral circulation rises. The patient may be subjected to a leukapheresis process several times where peripheral blood is removed and undergoes repeated selective separation and removal of leukocytes. After the patient receives HDC, the patient's bone marrow is reconstituted by the reinfusion of the stem cell population. Characteristics unique to either type of transplant or rescue make one preferable to the other in certain clinical situations. When marrow metastases preclude AuBMT, peripheral blood provides a suitable source of progenitor or stem cells for autografting. The most appropriate stem cell source for a particular patient depends upon his or her disease, treatment history, and the availability of a compatible donor. The most appropriate source of stem cells for each patient must be balanced by: 1. the risks of graft failure and reinfusion of malignant cells in autologous procedures, or 2. the risks of graft rejections and graft-versus-host disease in allogeneic procedures. This becomes critical with the advent of a mismatched or an unrelated donor pool. Umbilical Cord Blood (UCB) or Cord Blood (CB) contains blood cell progenitors and could become a source of stem cells. Stem cells and lymphocytes from cord blood lack the infectious disease resistance that mature blood cells possess by virtue of their prior exposure to various infectious diseases. Umbilical Cord Blood Transplantation (UCBT) or Cord Blood Stem Cells (CBSC) represents a major advance in providing HSCS to patients needing transplantation. Colony Stimulating Factors (CSF) are hematopoietic growth factors that stimulate the growth and maturation of bone marrow stem cells. Two of these CSFs are currently available: Granulocyte Colony Stimulating Factor (G-CSF) or Granulocyte Macrophage Colony Stimulating Factor (GM-CSF). Oncologists have identified that the functional status of the patient can be correlated with the outcome of the underlying disease. The following Karnofsky Performance Status Index (Scale) has been the most widely used measure of the functional status of cancer patients. GENERAL CATEGORY INDEX SPECIFIC CRITERIA Able to carry on normal activity, no special care needed 100 Normal, no complaints, no evidence of disease (same) 90 Able to carry on normal activity,
4 minor signs or symptoms of disease (same) 80 Normal activity with effort, some signs or symptoms of disease Unable to work, able to live at home and care for most personal needs, varying amount of assistance needed 70 Cares for self, unable to carry on normal activity or to do work (same) 60 Requires occasional assistance from others, but able to care for most needs (same) 50 Requires considerable assistance from others and frequent medical care Unable to care for self, requires institutional or hospital care or equivalent, disease may be rapidly progressing 40 Disabled, requires special care and assistance (same) 30 Severely disabled, hospitalization indicated, death not imminent (same) 20 Very sick, hospitalization necessary, active supportive treatment necessary (same) 10 Moribund (a dying state) N/A 0 Death RATIONALE: None DISCLAIMER:
5 State and federal law, as well as contract language, including definitions and specific inclusions/exclusions, takes precedence over Medical Policy and must be considered first in determining coverage. The member s contract benefits in effect on the date that services are rendered must be used. Any benefits are subject to the payment of premiums for the date on which services are rendered. Medical technology is constantly evolving, and we reserve the right to review and update Medical Policy periodically. HMO Blue Texas physicians who are contracted/affiliated with a capitated IPA/medical group must contact the IPA/medical group for information regarding HMO claims/reimbursement information and other general polices and procedures. Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation, a Mutual Legal Reserve Company* Southwest Texas HMO, Inc.* d/b/a HMO Blue Texas * Independent Licensees of the Blue Cross and Blue Shield Association Posted Jan. 7, 2003
Corporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationBlood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
More informationBone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation
More informationSEARCHING FOR A BONE MARROW DONOR
SEARCHING FOR A BONE MARROW DONOR Angela received a bone marrow transplant from an unrelated donor to treat her non-hodgkin s lymphoma. INFORMATION FOR PATIENTS AND THEIR FAMILIES For patients who need
More informationBlood-Forming Stem Cell Transplants
Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description
More informationHematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine
Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationHow To Save A Patient From A Cancer
BIOSTATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH Blood-&-Marrow Transplants & CANCERS Stem Cells Stem cells are immature body cells that act like "starter dough" because they can make identical copies
More informationCorporate Medical Policy Cord Blood as a Source of Stem Cells
Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description
More informationStem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
More informationHelping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer
More informationInfosheet. Allogeneic stem cell transplantation in myeloma. What is the principle behind stem cell transplantation?
Infosheet Allogeneic stem cell transplantation in myeloma High-dose therapy and autologous stem cell transplantation is currently the first-line treatment standard of care for younger/fitter myeloma patients.
More informationPANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR703.013
PANCREAS, PANCREAS-KIDNEY, SEGMENT OF PANCREAS AND ISLET PANCREATIC TISSUE TRANSPLANTATION SUR703.013 COVERAGE: A simultaneous or combined pancreas-kidney transplant (SPK) from a cadaver donor or a simultaneous
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationBone Marrow (Stem Cell) Transplant for Sickle Cell Disease
Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient
More informationBone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris
Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is
More informationCORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM
APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.
More informationStem Cell Background Paper
Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,
More informationSTEM CELL TRANSPLANTS
UAMS Information on STEM CELL TRANSPLANTS What is a Stem Cell Transplant? A stem cell transplant is an infusion of stem cells following high-dose chemotherapy. The infused cells effectively rescue the
More informationDEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT
www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers
More informationBlood and Marrow Stem Cell Transplantation
Blood and Marrow Stem Cell Transplantation Printing of this publication made possible by an education grant from Table of Contents Introduction 2 Overview of Stem Cell Transplantation 3 Normal Blood and
More informationPublic Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden
HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services
More informationReference: NHS England B04/P/a
Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation (HSCT) (All Ages): Revised Reference: NHS England B04/P/a 1 NHS England Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation
More informationUnderstanding Blood Stem Cell Transplantation
Developed by: Donna Kerrigan, M.S. Kathryn Hollen Jeanne Kelly Brian Hollen Discusses how bone marrow produces bloodforming stem cells that include starter immune cells. When diseases like cancer or its
More informationBlood cells are vital to the human body
Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200
More informationPERIPHERAL STEM CELL TRANSPLANT INTRODUCTION
PERIPHERAL STEM CELL TRANSPLANT INTRODUCTION This booklet was designed to help you and the important people in your life understand the treatment of high dose chemotherapy with stem cell support: a procedure
More informationUMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE
UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION
More information5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
More informationStem Cell Quick Guide: Stem Cell Basics
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
More information4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
More informationSevere Combined Immune Deficiency (SCID)
Severe Combined Immune Deficiency (SCID) ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Severe combined immune deficiency (SCID) is the most serious form of primary immune deficiency and is usually
More informationOther treatments for chronic myeloid leukaemia
Other treatments for chronic myeloid leukaemia This information is an extract from the booklet Understanding chronic myeloid leukaemia. You may find the full booklet helpful. We can send you a copy free
More informationA fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS
A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can
More informationCord Blood Stem Cell Transplantation
LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral
More informationGRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
More informationSAVE A LIFE... BY GIVING LIFE!
SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the
More informationHematopoietic Stem Cells, Stem Cell Processing, and Transplantation
Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, MD Director, Hemotherapy and Stem Cell Processing Facility E-mail: js2745@columbia.edu A 40-year old man with acute myelogenous
More informationBlood and Marrow Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA
Blood and Marrow Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA Table of Contents Introduction 1 Here to Help 2 Normal Blood and Marrow 4 Overview and Types of Stem Cell Transplantation 6 Stem Cell
More informationYOU RE A POTENTIAL MATCH
YOU RE A POTENTIAL MATCH Explore the Journey to Donation Edward, PBSC donor, with his wife, Andrea TABLE OF CONTENTS A patient needs you You re a potential match and next steps 3 Steps of the donation
More informationGeneral Information about Donating Blood Stem Cells
General Information about Donating Blood Stem Cells This document contains general information about joining the national Registry and donating blood stem cells. You could be the Questions & Answers Paul
More informationCPT Codes for Bone Marrow Transplant January 2015 James L. Gajewski, MD
The blood and marrow transplant field has 15 dedicated CPT codes. These CPT codes can be categorized into three groups: 1. Collection Codes 2. Cell Processing Codes 3. Cell Infusion Codes Collection Codes
More informationMEDICAL POLICY HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL RESCUE FOR AUTOIMMUNE DISEASES, INCLUDING MULTIPLE SCLEROSIS MP-9.
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): Effective Date: June 17, 2008 July 1, 2009- RETIRED I. DESCRIPTION/BACKGROUND High dose chemotherapy (HDC) involves the
More informationHow To Treat Leukaemia With Cord Blood Stem Cell
Cord blood for the treatment of acute lymphoblastic leukemia in young children By Caitlin McGreevy Kiara Paramjothy Pass with Merit RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract:
More informationUMBILICAL CORD BLOOD BANKING. A guide for parents
UMBILICAL CORD BLOOD BANKING A guide for parents This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please visit https://go.edqm.eu/transplantation.
More informationOn April 4, a group of physicians at the 37th annual
By Ronale Tucker Rhodes, MS Better gene sampling and newer transplant regimens are making stem cell transplantation possible for a host of disease states that previously were rarely considered for this
More informationBLOOD AND MARROW TRANSPLANT PROGRAM
BLOOD AND MARROW TRANSPLANT PROGRAM We offer a team approach to patient care that centers around our patients and their caregivers; we focus on providing comprehensive, holistic care for the best possible
More informationEUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases
! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center
More informationBlood and Marrow Stem Cell Transplantation
Blood and Marrow Stem Cell Transplantation Revised 2013 A Message from Louis J. DeGennaro, PhD President and CEO of The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society (LLS) is committed to
More informationStem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants)
Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants) What we ll cover here This document reviews bone marrow transplants and different types of stem cell transplants used to
More informationAutologous Transplant Patient Education Binder
Autologous Transplant Patient Education Binder Blood & Marrow Transplant Program Taussig Cancer Institute Copyright 1995-2013 The Cleveland Clinic Foundation. All rights reserved. Definitions of Terms
More informationHow To Treat Cord Blood
Published:October2011 Thestudyreviews,analyzesandprojects theglobalmarketforcordbloodstem Cels fortheperiod2006-2015 2011alrightsreserved PRODUCT SEGMENTATION Cord blood stem cells are those adult stem
More informationAcute myeloid leukemia (AML)
Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult
More informationThe future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca
The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant
More informationIntroduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each
Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including
More informationMultiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
More informationPros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa
Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem
More informationChallenges of Hematopoietic Stem Cell Transplantation. Robert J. Soiffer, MD Dana Farber Cancer Institute
Challenges of Hematopoietic Stem Cell Transplantation Robert J. Soiffer, MD Dana Farber Cancer Institute Hematopoietic Stem Cell Transplantation Objectives Deliver sufficient chemo-radio therapy to destroy
More informationGraft Versus Host Disease. About Graft Versus Host Disease Background. Writer: Maya Chaddah Editor: Lisa Willemse Reviewer: Armand Keating
Graft Versus Host Disease About graft versus host disease Background Symptoms, Prevention and Treatment How can stem cells help? Umbilical cord blood stem cells Mesenchymal stromal/stem cells (MSCs) Research
More informationAcute Myeloid Leukemia
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
More informationQ: Why is there a need for people to join the Be The Match Registry?
Q: Why is there a need for people to join the Be The Match Registry? A: Thousands of patients with blood cancers like leukemia and lymphoma, sickle cell and other life-threatening diseases depend on the
More informationCurrent Issues in Stem Cell Technologies. Lance D. Trainor, MD OneBlood, Inc.
Current Issues in Stem Cell Technologies Lance D. Trainor, MD OneBlood, Inc. Objective: The big picture of stem cell therapy Outline: Relevant definitions History of Stem Cell Therapy Hematopoietic Stem
More informationBone Marrow/Stem Cell Transplant
Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based
More informationCord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape
GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us
More informationUMBILICAL CORD BLOOD BANKING A guide for parents
UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.
More informationChapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation
Surgery Chapter 4 Section 23.1 High Dose Chemotherapy (HDC) And Stem Cell Transplantation Issue Date: November 1, 1983 Authority: 32 CFR 199.4(e)(5) and (g)(15) 1.0 CPT 1 PROCEDURE CODES 38205, 38207,
More informationMEDICAL POLICY POLICY TITLE
Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): Effective Date: April 15, 2008 July 1, 2009- RETIRED I. DESCRIPTION/BACKGROUND High dose chemotherapy (HDC) involves the administration
More informationAcute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
More informationBlood and Marrow Transplantation Services and QIPP
Blood and Marrow Transplantation Services and QIPP Contents 1. Executive Summary 2. Background 2.1 What is QIPP? 2.2 BMT services the current picture 2.3 QIPP and BMT services 3. Main Themes 3.1 Clinical
More informationUnit 1 Higher Human Biology Summary Notes
Unit 1 Higher Human Biology Summary Notes a. Cells tissues organs body systems Division of labour occurs in multicellular organisms (rather than each cell carrying out every function) Most cells become
More informationCHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation
More informationumbilical cord blood banking A guide for parents
umbilical cord blood banking A guide for parents 2 nd Edition 2016 This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please
More informationP R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation
TABLE OF CONTENTS About the European Group for Blood and Marrow Transplantation Haematopoietic Stem Cell Transplantation (HSCT): Key facts & figures EBMT Data - A foundation for cutting-edge research Clinical
More informationBone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer
Bone Marrow or Blood Stem Cell Transplants in Children With Severe Forms of Autoimmune Disorders or Certain Types of Cancer A Review of the Research for Parents and Caregivers Is This Information Right
More informationSelection of the Optimal Umbilical Cord Blood Unit
Karen Ballen, MD Selection of the Optimal Umbilical Cord Blood Unit Massachusetts General Hospital September, 2013 OUTLINE Cell Dose HLA Match Allele Level HLA C KIR Directional Mismatch NIMA HLA Antibodies
More informationPr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose
Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of
More informationspecific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins
Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes
More informationUmbilical Cord Blood Stem Cells Current Status & Future Potential
Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu
More informationCord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD
Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer
More informationMy Sister s s Keeper. Science Background Talk
My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating
More informationTRANSPLANT BASICS Understanding transplant and how it works
TRANSPLANT BASICS Understanding transplant and how it works Thuy, transplant recipient AT EVERY STEP, WE ARE HERE TO HELP As you journey through transplant, you re not alone. Be The Match is ready to help.
More informationA Cure for Sickle Cell Anemia and Thalassemia
IV Simpósio Internacional de Hemoglobinopatias A Cure for Sickle Cell Anemia and Thalassemia Bertram Lubin, MD and Mark Walters, MD 4 September 2007 Topics to be covered Cord blood: Importance and biology
More informationUmbilical Cord Blood Transplantation
Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults
More informationDonating stem cells. What s involved?
Donating stem cells What s involved? Revised February 2012 The diagnosis of a blood cancer can be a devastating event for patients, families and friends. It is therefore vital for everyone to have access
More informationASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Assemblywoman CHARLOTTE VANDERVALK District (Bergen) SYNOPSIS Requires hospitals to provide information to pregnant
More informationHAEMOPHILIA & UMBILICAL CORD BLOOD TRANSPLANT
HAEMOPHILIA & UMBILICAL CORD BLOOD TRANSPLANT Haemostatic System in Body Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system How Bleeding Stops Vasoconstriction Platelet
More informationObjectives. Cord Blood. Case 1. Case 1. Case 1. Case 1. To provide a framework for answering a family s questions about cord blood storage.
Cord Blood Should we save the baby s cord blood? Meghan A. Higman, MD, PhD Clinical Assistant Professor of Pediatrics Division of Pediatric Hematology/Oncology Assistant Professor of Oncology Pediatrics
More informationOUR JOURNEY THROUGH THE YEARS
The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist
More informationUMBILICAL CORD BLOOD HARVESTING & STORAGE
Protocol: TRP009 Effective Date: October 14, 2013 UMBILICAL CORD BLOOD HARVESTING & STORAGE Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 BACKGROUND... 2 CLINICAL EVIDENCE...
More informationHematopoietic Stem-Cell Transplantation for Epithelial Ovarian Cancer
Hematopoietic Stem-Cell Transplantation for Epithelial Ovarian Cancer Policy Number: Original Effective Date: MM.07.014 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO 01/23/2015 Section:
More informationCORD BLOOD BANKING FAQ
CORD BLOOD BANKING FAQ Cord Blood & Stem Cells Q: What is umbilical cord blood (UCB)? A: Bone marrow, peripheral blood and UCB constitute the three primary sources of stem cells. Cord blood, which, until
More information15 Stem Cell Research
15 Stem Cell Research t a l k it o v e r 1 c l a s s se s s i o n Overview Students read about current scientific research on and the social controversy over embryonic stem cells. On a KWL literacy strategy
More informationNot All Stem Cells are the Same
Cord Blood Banking and Transplantation Jennifer Willert, M.D. Hematology/Oncology Blood and Marrow Transplant Rady Children s Hospital San Diego Clinical Professor UCSD Not All Stem Cells are the Same
More informationSTEM CELL THERAPY. Dr.MANOJ
STEM CELL THERAPY Dr.MANOJ Stem cell treatments are a type of intervention strategy that introduces new adult stem cells into damaged tissue in order to treat disease or injury The ability of Stem Cells
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression
More informationA Public Cord Blood Bank for South Africa? i
No. 42/2007 A Public Cord Blood Bank for South Africa? i By Dr Robert Crookes MBChB (Wits), Dip. Internal Medicine (American Board of Internal Medicine, USA) Transfusion Medicine Consultant. South African
More informationUnderstanding Allogeneic Transplants. A guide for patients and families
Understanding Allogeneic Transplants A guide for patients and families NOTES CONTENTS PAGE Introduction 3 The Leukaemia Foundation 4 Bone marrow, stem cells and blood cell formation 7 Bone marrow and blood
More informationTreatment of low-grade non-hodgkin lymphoma
Produced 28.02.2011 Due for revision 28.02.2013 Treatment of low-grade non-hodgkin lymphoma Lymphomas are described as low grade if the cells appear to be dividing slowly. There are several kinds of low-grade
More informationGraft-versus-host disease (GvHD)
Graft-versus-host disease (GvHD) This information is an extract from the booklet Understanding donor stem cell (allogeneic) transplants. You may find the full booklet helpful. We can send you a free copy
More information